日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients

更正：循环肿瘤DNA可优化局限期小细胞肺癌患者的巩固免疫疗法

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02526-y
Yang, Yin; Wu, Yuqi; Zhao, Jingjing; Zhang, Tao; Fei, Kailun; Zhao, Xiaotian; Deng, Lei; Zhang, Zhihui; Jiang, Ying; Wang, Jianyang; Liu, Wenyang; Wang, Xin; Wang, Song; Bao, Hua; Wu, Xue; Zhu, Minyi; Ou, Qiuxiang; Tang, Wei; Wang, Luhua; Wang, Zhijie; Bi, Nan
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer

PRIME：一种基于液体活检的可解释人工智能模型，可提高非小细胞肺癌进展风险的预测能力

期刊:Military Medical Research
影响因子:22.9
doi:10.1186/s40779-025-00679-z
Wang, Yu; Xiang, Yong-Bo; Chen, Xiao-Wei; Zhang, Tao; Wang, Jian-Yang; Liu, Wen-Yang; Deng, Lei; Wang, Lu-Hua; Gao, Shu-Geng; Bi, Nan
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Long-term outcomes and clinical features of stage III non-small-cell lung cancer harboring ALK rearrangements: a multicenter retrospective study of 176 patients

ALK基因重排的III期非小细胞肺癌的长期预后和临床特征：一项纳入176例患者的多中心回顾性研究

期刊:Journal of the National Cancer Center
影响因子:9.4
doi:10.1016/j.jncc.2025.07.005
Tan, Fengwei; Jiang, Ying; Duan, Jianchun; Li, Renda; Cao, Jianzhong; Jiang, Wei; Li, Qiang; Zhang, Guochao; Duan, Jinghao; Wang, Yu; Wang, Zhijie; Li, Weihua; Ying, Jianming; Wang, Jie; Bi, Nan; He, Jie
肺癌
肿瘤
肿瘤免疫
ALK
细胞生物学
发表日期：2026
文献求助 收藏

Quantifying statistical cure in unresectable locally advanced esophageal squamous cell carcinoma treated with radiotherapy-based regimens: a cure model analysis with SEER validation

对接受放疗方案治疗的不可切除局部晚期食管鳞状细胞癌进行统计学治愈率量化：基于SEER验证的治愈模型分析

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2026.1768800
Wang, Nan; Zhang, Xiangyang; Zheng, Xiaoli; Wang, Xiaohui; Jiang, Ying; Zhang, Zhuangzhuang; Zhao, Yibo; Xiao, Yumeng; Yang, Shuhan; Zhu, Longxin; Tang, Xiance; Li, Baosheng; Li, Yexiong; Bi, Nan; Ge, Hong
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Comparing the Prognosis of Non-Small Cell Lung Cancer Patients Who Did Not Undergo Surgery After Neoadjuvant Chemotherapy Combined With Immunotherapy: A Retrospective Study

比较接受新辅助化疗联合免疫治疗后未行手术的非小细胞肺癌患者的预后：一项回顾性研究

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.70280
Ma, Zhenghui; Wu, Yuqi; Ji, Guangqian; Zhou, Zongmei; Wang, Xin; Wang, Jianyang; Liu, Wenyang; Deng, Lei; Wang, Wenqing; Yi, Junlin; Bi, Nan; Zhang, Tao
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients

循环肿瘤DNA可优化局限期小细胞肺癌患者的巩固免疫疗法

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02445-y
Yang, Yin; Wu, Yuqi; Zhao, Jingjing; Zhang, Tao; Fei, Kailun; Zhao, Xiaotian; Deng, Lei; Zhang, Zhihui; Jiang, Ying; Wang, Jianyang; Liu, Wenyang; Wang, Xin; Wang, Song; Bao, Hua; Wu, Xue; Zhu, Minyi; Ou, Qiuxiang; Tang, Wei; Wang, Luhua; Wang, Zhijie; Bi, Nan
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy

PACIFIC-5：一项针对不可切除的 III 期非小细胞肺癌患者，在同步或序贯放化疗后未出现疾病进展的情况下，进行度伐利尤单抗巩固治疗的 III 期临床试验

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-025-01768-1
Wu, Yi-Long; Wu, Lin; Bi, Nan; Cil, Timucin; Ge, Hong; Zhu, Zhengfei; Wang, Chih-Liang; Zhang, Wei; Lv, Dongqing; Mingyan, E; Sun, Jianguo; Pan, Yi; Krzakowski, Maciej; Dikilitas, Mustafa; Sendur, Mehmet Ali Nahit; Kim, Young-Chul; Yang, Yanjiao; Mao, Rui; Zhang, Biao; Wang, Luhua
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Long-term outcomes of postoperative radiotherapy for patients with pIIIA-N2 non-small-cell lung cancer after complete resection and adjuvant chemotherapy (PORT-C): a single-centre, randomized, phase 3 trial

完全切除和辅助化疗（PORT-C）后接受术后放疗的pIIIA-N2期非小细胞肺癌患者的长期疗效：一项单中心、随机、3期试验

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103503
Men, Yu; Bao, Yongxing; Bi, Nan; Zhou, Zongmei; Liang, Jun; Lv, Jima; Feng, Qinfu; Xiao, Zefen; Wang, Yan; Li, Junling; Wang, Jie; Gao, Shugeng; He, Jie; Hui, Zhouguang; Wang, Luhua
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Efficacy and safety of oral vinorelbine with concurrent radiotherapy in unresectable stage III non-small cell lung cancer following neoadjuvant chemoimmunotherapy: a single-arm, phase 2 trial

新辅助化疗免疫治疗后，口服长春瑞滨联合放疗治疗不可切除的III期非小细胞肺癌的疗效和安全性：一项单臂II期试验

期刊:Journal of the National Cancer Center
影响因子:9.4
doi:10.1016/j.jncc.2025.06.004
Lian, Xinrong; Shayan, Gulidanna; Yang, Shijie; Liu, Wenyang; Zhang, Tao; Lv, Jima; Wang, Wenqing; Wang, Jianyang; Wang, Xin; Xiao, Zefen; Zhou, Zongmei; Bi, Nan; Deng, Lei
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

The application and prospect of granzyme B-targeted PET imaging in cancer immunotherapy

靶向颗粒酶B的PET成像在癌症免疫治疗中的应用及前景

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-07419-w
Tong, Xu; Jiang, Ying; Bi, Nan
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏